बुधवार, 19 मई 2021

Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies



from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2S7EhLa
via IFTTT

लेबल:

0 टिप्पणियाँ:

एक टिप्पणी भेजें

सदस्यता लें टिप्पणियाँ भेजें [Atom]

<< मुख्यपृष्ठ